U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220785) titled 'Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy' on Oct. 22.
Brief Summary: This study is researching a new drug called mibavademab (called "study drug"). The study involves participants with a condition called Generalized Lipodystrophy (GLD). The aim of the study is to see how well mibavademab works and what side effects it has. Researchers will also look at how much mibavademab is in the body at different times.
This is a 2-part study: Part A is an efficacy study in pediatric and adult participants, Part B is a safety and pharmacokinetic study in pediatric participants.
The study...